Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2022   1,569,943    
Balance, amount at Dec. 31, 2022 $ (10,622) $ 1,570 $ 115,792,338 $ (115,804,530)
Employee and director equity-based compensation 242,102 0 242,102 0
Net loss for the three months ended March 31, 2023 (1,973,142) $ 0 0 (1,973,142)
Balance, shares at Mar. 31, 2023   1,569,943    
Balance, amount at Mar. 31, 2023 (1,741,662) $ 1,570 116,034,440 (117,777,672)
Balance, shares at Dec. 31, 2023   2,382,356    
Balance, amount at Dec. 31, 2023 (2,205,843) $ 2,383 121,373,488 (123,581,714)
Employee and director equity-based compensation 112,104 0 112,104 0
Net loss for the three months ended March 31, 2023 (1,278,486) $ 0 0 (1,278,486)
Private sales of common stock - other, shares   350,633    
Private sales of common stock - other, amount 972,544 $ 351 972,193 0
Private sales of common stock - related party, shares   56,666    
Private sales of common stock - related party, amount 130,782 $ 57 130,725 0
Balance, shares at Mar. 31, 2024   2,789,655    
Balance, amount at Mar. 31, 2024 $ (2,268,899) $ 2,791 $ 122,588,510 $ (124,860,200)